Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo molecule, E-6011, represents a promising treatment focused on the PD-1 receptor. Early medical findings from the two studies, KANAb 001 and E-6011, reveal positive response in multiple tumor types. Specifically, data point to a likely improvement in patients with resistant malignancies, des